No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY FRANCE

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

Cisionby Cision
June 6, 2023
Reading Time: 4 mins read
in FRANCE, PRIVATE EQUITY
Share on FacebookShare on Twitter

ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group. With this strategic alliance, PLG, a global provider of regulatory and compliance services for the life sciences industry, reinforces its ability to tackle the Italian market on its core services and positions itself as a global leader in the industry. With more than two hundred and fifty employees, Pharma D&S Group is PLG’s largest build-up to date.

PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ — ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

 ProductLife Group Logo

Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner. It strengthened its service offering on Regulatory Affairs, Product Quality and Process Compliance, Pharmacovigilance and Clinical Operations activities. In 2004, the Group launched Pharma Education Center (PEC), a training provider for the Life Sciences sector. In 2005, the two partners were joined by Marco Conti who founded C&P Engineering a consulting entity providing high-quality services specialized in pharmaceutical process engineering, qualification and computer systems validation.

This new deal is a key step in PLG’s growth, making up for a company of more than one thousand and two hundred employees with a strong and expert presence across the globe. For Xavier Duburcq, CEO of PLG, "Pharma D&S Group is a renowned leader on the Italian market with a long standing emphasis on quality and expertise. The synergies between our two companies are high, and our values and corporate cultures have a lot in common, thanks to the entrepreneurial spirit at both PLG and Pharma D&S Group."

"Twenty years after launching Pharma D&S Group, I am convinced that joining PLG is the future of our organization", says Riccardo Ballerini, Founder and Chairman of Pharma D&S. "The merger with PLG provides our clients and the life sciences industry with access to a global footprint and a more robust combined set of capabilities across all of our key value areas".

Lino Fabrizi, COO of Pharma D&S, further shares: "This strategic alliance will provide a good opportunity for our team to expand their careers, and it will give our business strong support functions to facilitate sustainable growth. We strongly believe that our two organizations share the same DNA which will result in a stronger quality of service provided to our clients."

For Marco Conti, Founder and CEO of C&P Engineering, "being part of PLG is the opportunity to provide our tailored made quality design and qualification expertise to a wider range of clients across Europe, enlarging the offering and leveraging the strong network that PLG already has today."

About ProductLife Group:

ProductLife Group’s mission is to improve human health by delivering regulatory & compliance services for the safe and effective use of medical solutions. PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of drug development, regulatory affairs, quality management and compliance, vigilance and medical information, covering both established products and innovative therapeutics & diagnostics. 
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. 

For more information, visit https://productlifegroup.com/

Contact
Fabrice Galzin
ProductLife Group Head of Marketing
fgalzin@productlife-group.com
+33 (0) 672 349 606

Pharma D&S Group

Pharma D&S Group’s mission is to provide pharmaceutical and life science companies with all the specialized services they need the most. Pharma D&S Group offers its customers reliable, efficient and personalized support during every process that affects the life cycle of their products from development to post marketing, from process engineering to facilities design, construction and qualification. Developed through a wide variety of multidisciplinary expertise, Pharma D&S Group’s solutions are customizable and flexible to help clients overcome the complex challenges of an ever-changing business.
Pharma D&S Group is made of three companies Pharmaceutical Development and Services, C&P Engineering and PEC – Pharma Education Center.

For more information, visit https://www.pharmades.it/

Contact
Andrea Pieri 
Sales and Marketing Director
apieri@pharmades.it

Logo – https://mma.prnewswire.com/media/2082589/4048012/PLG_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/productlife-group-announces-its-intention-to-merge-with-pharma-ds-group-expanding-its-overall-offering-and-italian-footprint-301842883.html

Read the orginal article: undefined

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

PRIVATE EQUITY

Company brags about its ‘deal-making expertise’ after advising on sale of Chancellors to LRG

May 9, 2025
PRIVATE DEBT

Aker Carbon Capture has decided to sell its 20 percent ownership interest in SLB Capturi to Aker, targeting cash distribution to its shareholders and subsequent liquidation

May 9, 2025
GREEN

Aker Horizons announces merger with Aker and early repayment of NOK 2.5 billion green bond

May 9, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH

evroc reveals plans to build Europe's first sovereign hyperscale cloud

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart